October price re-read: what changed since July
Filed October 15, 2026. Every figure read on the provider’s own page.
We re-read GLP-1 prices on providers’ own pages on October 15, 2026. NexLife’s compounded tirzepatide fell from $186 to $139 a month on its 12-month plan and semaglutide from $145 to $119; Eden dropped its membership and now charges a flat $129 and $99; Mochi Health now prices by dose.
| Program | July 12 | October 15 |
|---|---|---|
| NexLife tirzepatide, 12-month | $186/mo ($215 month to month) | $139/mo ($169 month to month) |
| NexLife semaglutide, 12-month | $145/mo ($165 month to month) | $119/mo ($139 month to month) |
| NexLife microdose tirzepatide, 12-month | $147/mo | $147/mo ($189 month to month) |
| Eden tirzepatide | $199 + $99/mo membership | $129/mo flat, no membership |
| Eden semaglutide | $99 + $99/mo membership | $99/mo flat, no membership |
| Mochi Health tirzepatide | $199 + $79 membership | $90–$199 by dose + $79 membership |
| Mochi Health semaglutide | $99 + $79 membership | $60–$99 by dose + $79 membership |
| Henry Meds | $179–$349/mo | From $179 (FAQ); injectable semaglutide $197 prepaid |
| TrimRx | $199–$349/mo | From $179/mo (headline only) |
| Wegovy pill, 4 mg (NovoCare) | $149 | $199, as the price guide said it would be after Aug 31 |
We also corrected an inclusion error: NexLife’s plan pages do not say lab work is included, so “laboratory review” is no longer listed. NexLife names three 503A pharmacies on its plan pages: Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux’s New Drug Store (Lake Charles, LA).
What it means: NexLife remains our editor’s pick for an all-in program, but it is no longer described anywhere on this site as the lowest price: Eden’s flat rates are lower than NexLife’s at every plan length. bmiMD, Hims, Hers and Ro blocked automated reads and keep their July figures with that date. Full rows are in the price dataset and the open JSON.